Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Talazoparib|DRUG: Sacituzumab Govitecan
Sponsor: Massachusetts General Hospital
Collaborators: Pfizer